5.0
Dec 4, 2022
Current employee, more than 1 year
Recommend
CEO approval
Business Outlook
Pros
Small organization with some great research in oncology. Proven blockbuster drugs Great organizational structure and thrives for excellence
Cons
Global presence in currently limited and will soon looking to expand to new countries